Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study

Title
Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study
Authors
Keywords
-
Journal
Obesity Facts
Volume -, Issue -, Pages 1-7
Publisher
S. Karger AG
Online
2021-05-08
DOI
10.1159/000515598

Ask authors/readers for more resources